Αποτελέσματα Αναζήτησης
28 Αυγ 2023 · Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, risk factors, and screening; Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Treatment and prognosis; Recurrent pericarditis; Risk factors for and possible causes of systemic sclerosis (scleroderma)
- Contributors - UpToDate
Overview of the treatment and prognosis of systemic...
- Clinical manifestations and diagnosis of systemic sclerosis ... - UpToDate
Pulmonary arterial hypertension in systemic sclerosis...
- Contributors - UpToDate
9 Ιαν 2023 · The five-year survival rate for diffuse cutaneous systemic sclerosis is about 84%, while the five-year survival among patients with limited skin (cutaneous) systemic sclerosis is over 90%.
3 Απρ 2019 · To describe survival, standardized mortality ratio (SMR), and prognosis factors in systemic sclerosis (SSc), we analyzed a multicenter French cohort of incident patients and performed a systematic review of the literature and meta-analysis.
5 Απρ 2024 · On the other hand, diffuse cutaneous systemic sclerosis involves skin thickening that may affect areas proximal to the elbows, knees, face, and/or trunk. Both limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis are associated with several systemic manifestations and positive autoantibodies.
15 Ιουν 2024 · Scleroderma (sklair-oh-DUR-muh), also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. Scleroderma also may cause problems in the blood vessels, internal organs and digestive tract.
27 Νοε 2021 · People with either diffuse or limited cutaneous scleroderma may have: • Raynaud phenomenon • Heartburn and other esophagus problems, like trouble swallowing food • Skin sores, usually on the fingers, but possibly in the wrists, elbows or ankles • Tummy grumbles, feeling “full” after eating only a small of amount of food, bloated or
18 Απρ 2023 · Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Treatment and prognosis; Pulmonary hypertension due to lung disease and/or hypoxemia (group 3 pulmonary hypertension): Epidemiology, pathogenesis, and diagnostic evaluation in adults; Risk factors for and possible causes of systemic sclerosis (scleroderma) Society guideline ...
